Neurophet and ReadyCure said they have signed a business agreement to exchange business and conduct projects related to developing an Alzheimer's disease treatment.

Under the accord, Neurophet will cooperate on developing ReadyCure's upcoming dementia treatment medical device, Helaxon.

Utilizing its advanced brain neurodegeneration imaging software, Neurophet AQUA, Neurophet plans to support the analysis of brain images necessary for the treatment process of Alzheimer's dementia using clinical data provided by ReadyCure.

Neurophet's AQUA, an AI-driven software, has been developed to analyze abnormal brain atrophy and white matter degeneration found in Alzheimer's patients' MRI scans.

ReadyCure, founded by Jung Won-kyu, a professor at Kyung Hee University Hospital at Gangdong's Department of Radiation Oncology, is a bio-startup focused on developing new Alzheimer's treatment methods using digital X-ray technology.

This approach seeks to overcome the limitations of drug treatments and their side effects by employing digital X-rays to transform microglia cells, a type of immune cell in the brain, offering a novel method of treating dementia.

Traditionally, dementia treatments have focused on eliminating amyloid-beta and tau proteins, known contributors to the disease. However, this joint project proposes a new therapeutic direction by utilizing ReadyCure's digital X-ray technology to modify the properties of microglia cells.

"Our cooperation with Neurophet is expected to develop a new paradigm of non-pharmacological dementia treatment technology," ReadyCure CEO Jung said. "This research and development effort will contribute to making dementia a manageable condition, similar to diabetes or hypertension."

Neurophet CEO Been Jun-kil also said, "With the Alzheimer's treatment market expanding, the importance of utilizing brain image analysis for diagnosis and treatment prescription monitoring is becoming more pronounced."

Neurophet anticipates integrating it's brain imaging analysis technology with ReadyCure's innovative dementia treatment research will yield excellent results, Been added.